IRINOTECAN HCL

Apotex

Formula & Concentration

IRINOTECAN HCL – irinotecan 100 mg/5 mL intravenous solution

Manufacturer

Apotex Corp

Indications

Metastatic colorectal cancer; malignancy; non-small cell lung cancer; anaplastic astrocytoma; small cell lung carcinoma; glioblastoma multiforme; refractory Ewing’s sarcoma

Product Options

Package Size

NDC #

Presentation

100 mg/5 mL

60505-6128-01

Vial

Shelf Life and Storage

Controlled Room Temp (20-25°C)